Opioid abuse is one of the greatest health problems around the world. There have been recent increases in worldwide use of heroin, particularly in the USA and Western and Central Europe.
Introduction
Heroin (diacetylmorphine or diamorphine (BAN)) is an opioid analgesic that is abused by around 16.5 million people worldwide and in 2015 was responsible for an estimated 150,000 deaths 1 . The use of heroin is however changing around the world. Europe is currently seeing a recent increase in deaths after seeing a long term decline in the use of heroin 2 , this increase in abuse is also being seen in other parts of the world such as South West and Central Asia 1 .
North America in particular has seen a large 145% increase in heroin users since 2007 1 .
Although there has been a recent increase in the use and abuse of synthetic opioids worldwide 2 the abuse of heroin is still a global problem to be addressed. Heroin is commonly abused by various routes the most common ones being intravenously, orally and inhalation (smoking) 3 .
Heroin, once absorbed, is rapidly deacetylated and pharmacologically activated by metabolism with the formation of 6-monoacetylmorphine (6-MAM) with a half-life of about 2-5 minutes 4 . 6-MAM is then hydrolysed rapidly to morphine (t½ ~15 min). The major final steps of the metabolism of morphine are the conjugation of morphine to form the pharmacologically inactive morphine-3-glucuronide (M3G) and the pharmacologically active morphine-6glucuronide (M6G). N-demethylation of morphine also results in the formation of the inactive minor metabolite normorphine 5 . Due to various factors it is difficult to interpret postmortem morphine concentrations. These factors include overlapping concentrations of morphine measured in deceased and living patients 6 , the rapid development of tolerance to opiates in users 6 and the possibility of changes in the blood concentration of opiates after death 7 . Due to the routine introduction of LC-MS/MS into laboratories it is becoming more common to quantitate the concentrations of morphine, morphine-3-glucuronide and morphine-6glucuronide in post mortem samples 8, 9 rather than to determine the concentration of free morphine and total morphine levels (free + conjugated morphine levels) to determine possible toxicity 10 . To fulfill the lack of information and help colleagues in data interpretation we report the concentration of morphine, morphine-3-glucuronide and morphine-6-glucuronide whilst also showing qualitative results for noscapine, papaverine and codeine in 44 cases in a series of commonly sampled postmortem matrices (femoral blood, cardiac blood, brain (thalamus), liver (deep right lobe), bone marrow (sternum), muscle (psoas) and (vitreous) using a validated LC-MS/MS method.
Material and Methods

Sample collection
All samples were collected and analysed as part of the routine autopsy procedure for suspected heroin deaths (2010) (2011) (2012) . These samples included femoral venous blood (unpreserved sample and preserved sample with potassium fluoride/sodium oxalate), unpreserved cardiac blood, muscle (psoas), bone marrow (sternum), liver, brain (thalamus) and preserved vitreous humour.
Sample collection was performed according to the following protocol:
All fluid samples (blood, vitreous) were collected using a 12 gauge needle and syringe.
Unpreserved fluid samples were stored in a 20 ml Sterlin® tube. Preserved samples were stored in a 2.5% w/v sodium fluoride/potassium oxalate tube. Femoral venous blood was collected by the superior clamping of the femoral vein before sampling. Cardiac blood was sampled for either of the ventricles. Vitreous humour was sampled from both eyes and mixed. For all tissue samples the area was wiped clean before sampling commenced, samples were stored in 20 ml Sterlin® tubes. For psoas muscle sampling an incision was then made anteriorly to remove approximately 1cm 3 of interior tissue to minimise external contamination. For liver an incision was made across the middle right lobe to provide a 1cm 3 of centrally located tissue to avoid external contamination. For bone marrow the sternum was cut laterally between the 1 st and 2 nd rib to allow access to the bone marrow. Tweezers were used to collect between 0.5 -1 g of bone marrow from the sternum cavity. For the brain approximately 1 cm 3 of the thalamus was wiped clean then collected. Samples were stored at 4ºC for 1 week and then stored at -20 ºC until analysis. All analysis was completed with 5 weeks of the samples being collected.
Standard Solutions, Calibration Curve and Quality Control
Morphine (1mg/ml), morphine-3β-D-glucuronide (M3G) (1mg/ml) and morphine-6-β-D- 
Sample Preparation and extraction
Tissue Sample Preparation
For extraction, liver, brain, bone marrow and muscle were homogenised, adapting and applying a previous published procedure 11 . In summary tissues were dried using tissue paper, accurately weighted and homogenised (Janke & Kunkel Ultra-Turrax T25) with 4 parts of water.
Thalamus and bone marrow were accurately weighted and homogenised with 2 parts of methanol and 6 parts of hexane. The methanol/hexane homogenates were then centrifuged and the top hexane layer discarded.
Sample Extraction
The sample extraction was based on a previously published method 10 The qualitative and quantitative screening were based on a previously published method 10 . For the qualitative screening a gradient method was applied. Following injection the eluent was at 1.5% ACN (97% A, 3%B) for the first 3 min, ramping to 47.5% ACN over 5 min (5% A, 95%B) and held for 3.5 min. The eluent was then reduced back to the initial 1.5% ACN over 0.5 minutes and was held for a further 3 minutes. This gave a total run time of 15 minutes.
Flow rate was 0.6 ml/min, injection time was 20 seconds and column temperature was set at 40 °C. The injection volume was 20l. Free morphine, M3G and M6G quantitation was achieved with an isocratic method of 1.5% acetonitrile (97% A, 3%B). The triple-quadrupole linear ion trap mass spectrometer performed the scan in positive mode using ion spray ionization (voltage 5500 V). The ion source temperature was set at 700 °C, DP 20 V, EP 10 V.
Method Validation
The method was validated according to the guidelines of Peters et al. 12 , with the matrix effects being evaluated by the methods of Matuszewski et al. 13 
Statistical Analysis
Morphine results obtained from all biological matrices underwent statistical Pearson Correlation analysis to determine whether any linear relation exist between different samples.
The data was also analysed using "Principal Component Analysis" (PCA).
PCA is an unsupervised multivariate procedure and is a well-known linear data compression and feature extraction technique 14 . It derives new, uncorrelated variables that are linear combinations of the original variable set ordered by reducing variability. PCA is mainly used to reduce the dimensionality of a data set while retaining as much information as possible by eliminating the lowest-ranking variables. It is a simple and fast method but remains a linear approach, so any nonlinear correlation between variables will not be retained. The scores produced may be plotted in two or three dimensions to inspect the data. Therefore it might be possible to relate the data using statistical methods such as principal component analysis (PCA).
Results and Discussion
A total of 44 cases of death from heroin use were investigated. The presence of 6monoacetylmorphine (6-MAM) in at least one of the case samples and the case circumstances were used as confirmation of illicit rather than medicinal heroin use. Each sample collected at autopsy (cardiac blood, femoral blood, preserved (fluoride/oxalate) femoral blood, preserved vitreous, liver, bone marrow, psoas muscle and brain) underwent initial qualitative screening for morphine, morphine-3-glucuronide, morphine-6-glucuronide, codeine, 6-MAM, papaverine and noscapine). Following the quantitative screen the levels of free morphine, morphine-3-glucuronide and morphine-6-glucuronide were determined in all samples.
Age and gender of heroin users
Of the 44 cases of death following heroin use 79.5% were male with a mean age of 36 years;
(median 35 years; range 21 to 65 years). 20.5% were female with a mean age of 34 years, (median 33 years; range 21 to 46 years). The mean and median age for all cases (regardless of sex) was 35 years. Averages for age and gender were similar to previous other studies of heroin related fatalities 6, 15
Qualitative Screening
In the case of decomposition the full range of toxicological samples may not be available for testing. In order to determine the samples in which morphine, morphine-3-glucuronide and morphine-6-glucuronide can be detected we carried out qualitative screening of blood (femoral and cardiac), vitreous, liver, brain (thalamus), muscle (psoas) and bone marrow. The results of the qualitative screening are found in Table 2 . The presence of morphine was confirmed in all cases for cardiac blood, unpreserved femoral blood, preserved femoral blood and vitreous with high levels of detection of morphine and in brain, liver, bone marrow and muscle samples (98%, 95%, 91% and 86% detection) respectively. Similar to the study by Thaulow et al 16 , morphine-3-glucuronide was detected in all case samples for cardiac blood and unpreserved femoral blood. High levels of detection were observed in all other matrices; preserved femoral blood (98%), brain (84%), liver (98%) bone marrow (75%) samples, vitreous (95%) and muscle (84%) samples. Previous work 16 has only determined detection of M3G in vitreous (88%) and muscle (89%) which are similar to our data. Thaulow et al. 16 in agreement with our data detected morphine-6-glucuronide in fewer matrices than morphine and morphine-3glucuronide, in our data M6G exhibited with high rates of detection >86% in all samples apart from muscle (50%) bone marrow (41%) and thalamus (43%). This would be expected as more M3G is produced by metabolism of morphine than M6G 17 . However we detected M6G in psoas in a higher number of cases (50% vs 9%) and also in vitreous humour (84% vs 44%) than the Thaulow et al. study 16 . These results suggest that the best matrices for the confirmation of free morphine and its glucuronide metabolites are blood (femoral and cardiac) > liver > vitreous. In muscle, bone marrow and brain, morphine will be detected in most cases but not all of the time. This may mean that in decomposed bodies the use of morphine may not be able to be confirmed even if the deceased had taken morphine. The presence of morphine and its main metabolites morphine-3-glucuronide and morphine-6-glucuronide have previously been reported in a number of human cases for various matrices and give similar results to those that we found in this study with morphine-3-glucuronide and morphine-6-glucuronide detectable in blood, vitreous, brain, liver, lung and kidney [18] [19] [20] [21] [22] [23] [24] .
The presence of morphine alone does not confirm the use of heroin as morphine can be produced as a metabolite of codeine and morphine can be abused by itself. In order to definitively identify the use of heroin, 6-MAM needs to be detected. However 6-MAM is unstable in the body being metabolised even after death by cholinesterases. With particularly high concentrations of esterases found in liver, heart, lung, kidney and blood 25 . Our study shows that as with other studies 24, 26, 27 vitreous is the best sample for the detection of 6-MAM being detected in 100 % of cases. In blood the 6-MAM was most stable in fluoride/oxalate preserved samples where it was detected in 61% of samples. In all other matrices 6-MAM was detected in <52% of case the worst samples for the detection of 6-MAM was liver and bone marrow (2% and 5% respectively). However it is unclear why so little 6-MAM was detected in bone marrow as in previous human and animal studies 6-MAM has been shown to be detectable 2 months after death 23, 28 . This may be due to the different sampling sites used between this study (sternum) and the previous studies (both femur) or a lack of time for 6-MAM to equilibrate with the bone marrow compartments before death occurred.
Another important piece of information that can be obtained from toxicological screening is the determination of the use of heroin which can come from either illicit or medicinal (diamorphine) sources. The illicit heroin contaminants which occur in the largest amounts due to the processing of the opium poppy are noscapine, papaverine, codeine, 6-acetylcodeine, thebaine, and narceine 29 . The most commonly used biomarkers for illicit heroin are noscapine and papaverine as they are found in the opium poppy and have been found to survive the common two methods of heroin production, the lime method (South East Asia) and the ammonia method (West Asia) 30 . The amount of noscapine and papaverine has been found to vary based on the batches of heroin. In 513 illicit seizures of heroin from the Netherlands between 1994-1999 noscapine was detected in 15% and papaverine detected in 1.3% (median values) 29 33 . Several studies show that noscapine and papaverine are not present in illicit heroin samples and therefore negative results do not infer that illicit heroin was used. Use of illicit heroin attributed due to the presence of noscapine and papaverine should be done after excluding their provenance from other prescribed drugs and from patient given atracurium.
Overall for all compounds investigated we found a slightly higher percentage of positive cases for preserved matrices (blood and vitreous) showing that more information can be gained from preserved blood samples compared to unpreserved blood samples.
Quantitative results:
Interpretation of the postmortem results requires investigation (case history), pathology and also laboratory analysis that are evaluated in the context of each other 34 . In order for laboratory investigations to be placed into correct context data must be obtained from case studies of heroin death. To the best of the authors' knowledge this is the first publication that has complete case studies for heroin deaths in a variety of matrices with both free morphine and its glucuronides. We determined the concentrations of free morphine, morphine-3-glucuronide and morphine-6-glucuronide in a variety of matrices as shown in Table 3 . An overall summary of the results are given in table 4. The general consensus is that 'gold standard' sample for interpretation in postmortem toxicology is that of femoral blood which is thought to be affected the least by the "toxicological nightmare" of postmortem drug redistribution 7 . The free morphine levels in unpreserved femoral blood (median 0.21 mg/L, range 0.01-1.35mg/L, n=44)
were not found to be significantly higher than that found in preserved femoral blood (median 0.14 mg/ L, range 0.01-1.19 mg/L, n=44). As can be seen in table 5 the mean values of free morphine are similar to a variety of other studies that reported free morphine levels in femoral blood. These results overlap with the free morphine blood levels reported in apprehended drivers in Sweden median 0.15 mg/L range 0.02-1.13mg/L. n=124 6 and so confirm other reports that the confirmation of death due to morphine must be confirmed from as much case information as possible rather than looking at drug reference ranges 35 . The morphine results that have typically been used in the past to determine the role of morphine in opiate deaths has been that of free morphine (unmetabolised morphine) and total morphine (unmetabolised morphine and metabolised morphine). However this does not allow investigation of the individual roles of the glucuronide metabolites in opiate toxicity. Due to the lack of previous studies, especially in non-blood matrices studies we also investigated the levels of morphine-3-glucuronide and morphine-6-glucuronide. The results are shown in table 2 and 3 as shown in table 5 these results are similar to the ranges that have been reported in previous studies that measured femoral blood. It has been suggested that the molar ratio of M3G:M6G might be responsible for the analgesic effect (and thus toxic effects of morphine) 36 however this is based on the assumption that M3G antagonises the analgesic (and also respiratory depressant) effects of M and M6G. This effect has been demonstrated in vivo following intracerebroventricular injections 37, 38 but has not been repeated in either animal studies 39, 40 or human studies in the more physiologically relevant intravenous injection 41 . So the M3G:M6G ratio is unlikely to indicate the effects of morphine as previously suggested. Its relevance has also been called into question as we would have to assume that no detectable levels of both M3G and M6G were present before the administration of heroin, something that may not be true in chronic heroin/morphine users. It has also been found that the metabolites are not produced in equal amounts and that the amounts of glucuronide metabolites can depend on the route of administration 17 .
Morphine-6-glucuronide has been shown in numerous studies to have a similar or greater analgesic potency than morphine [41] [42] [43] , like morphine it is also thought to give a similar level of reward as morphine [44] [45] [46] but appears to have less of a respiratory depressant effect than morphine in human studies 47 possibly due having less affinity for the 2 opiate receptor than morphine. The 2 opiate receptor is thought to be responsible for the side effects of opiate drugs. Both morphine and M6G have similar affinities for the 1 receptor 48, 49 .
In all cases the concentrations of free morphine, morphine-3-glucuronide and morphine-6glucuronide were higher in cardiac blood than femoral blood. This was as expected as in previous studies that investigated both cardiac and femoral blood the cardiac blood was generally found to be higher than the femoral blood [50] [51] [52] . Two studies have shown concentrations of free morphine that have been higher in femoral blood than cardiac blood. In one case the cardiac morphine concentration was 0.8mg/L (left ventricle), 0.46mg/L (right ventricle) with a femoral blood of 1.35mg/L 20 . In a study performed on 4 cases of heroin related deaths Skopp analysed the concentration of morphine, M3G and M6G sampling the blood from different sites: aorta, infra-and suprarenal potion of inferior vena cava, the superior vena cava, the femoral and subclavian vein, right and left ventricles 53 . Case number one showed concentration of cardiac blood (left and right ventricle) for all three compounds higher than the one in femoral blood (left and right femoral vein). For the second case morphine concentration in the blood from the right ventricle was lower than the blood in the right femoral vein. In the same case M6G was overall higher in cardiac blood than femoral blood. M3G was not quantifiable in cardiac blood due to biological matrix interferences. The third case morphine in left femoral blood was lower than the left ventricle but higher than the right ventricle, and also M6G presented a higher concentration in the blood from the left femoral vein than the blood of the left ventricle. Case four had a lower concentration for M3G and M6G
in the blood from the left ventricle than the right and left femoral vein.
Liver was historically a common tissue for toxicological analysis due to its large mass. We also investigated the free morphine & morphine glucuronide metabolites in the right lobe of the liver a part of the liver that is thought to be the least effected by postmortem redistribution, especially from the stomach 7 . Concentrations of free morphine in liver showed a mean concentration of 0.62mg/kg with a range of 0-2.55mg/kg, M3G was 0.7mg/kg (range 0-4.68), M6G was 0.29mg/kg (range 0-1.76). We are the first study to show free morphine and the glucuronide metabolites of morphine in liver samples. Only Klingman reported in study of one case (intoxication following morphine, tramadol and atracurium intake) the concentration of morphine as well M3G and M6G in liver which were 2.32, 14.94 and 15.1 mg/kg respectively 55 . Three other studies investigated free morphine concentrations alone. Wyman analysed 25 heroin deaths. Morphine concentration in liver averaged 0.04-1.56 mg/kg (mean 0.33 mg/g) so slightly lower than our results 18 . Moriya described just one case with a morphine concentration of 1.44 mg/kg 20 . Felby investigated morphine concentration in the liver of 14 heroin deaths.
The range reported was 0.4-18 mg/kg, average 2.57mg/kg 21 . In our study liver was the biological matrix showing the highest mean concentration of morphine (0.62 mg/kg). In the other studies investigating liver they also found liver to contain the highest concentration of morphine of all the matrices tested 18, 20, 21, 54 . The high concentrations of morphine and metabolites in the liver may mean that the liver is a possible depot for postmortem redistribution.
Muscle is commonly used for detection of morphine use rather than for interpretive purposes 55 . However it has been suggested that muscle may give a reasonable estimate of the concentration of a drug in the body at the time of death 56 . We quantitated free morphine, M3G
and M6G in the psoas muscle. Results given as mean and range. Morphine 0.19mg/kg, 0- Bone marrow has been suggested as a possible source of information about morphine in decomposed bodies due to bone marrow being protected from the environment in decomposition situations 23 . We found that the mean concentration of free morphine in bone marrow was 0.25 mg/kg range 0-3.23 mg/kg. This was similar to the bone marrow morphine level found in a heroin addict immediately after death (0.2 mg/kg). It is unclear if the concentrations of morphine vary depending on the bone marrow sampling site.
The brain is an important site of action for the respiratory depressant effects of morphine, the effect that is thought to cause death in heroin fatalities 58 . We investigated the concentration of free morphine in the thalamus. The mean concentration of free morphine was 0.26 mg/kg (range 0-1.96 mg/kg); M3G 0.06mg/kg, 0-1.12 mg/kg; M6G 0.01 mg/kg. Previous studies have looked at the concentrations of morphine in the brain, but as with other tissues there is no standard sampling site. One study looked at two regions in the brain medulla (mean 0.24 mg/kg range 0.05-0.45mg/kg) and cerebellum (mean 0.34 mg/kg, range 0.05-0.67mg/kg) 59 . These results were similar to those that we obtained but may indicate that the concentration of morphine is not uniform thorough out the brain and for future comparison of cases specific sampling sites should be identified. Other cases where the brain was analysed also gave similar concentrations as found in our study. Moriya 20 presented the results of a subject who died after injecting heroin and methamphetamine. Cerebrum was analysed morphine concentration was 0.34 mg/kg. In another study 22 Pare analysed morphine concentration in the thalamus 0.24 mg/kg (range 0-0.67 mg/kg). Only one study investigated the concentration of morphine as well as its metabolites in and unidentified area the brain. Klingmann found the concentration of morphine was 0.52 mg/kg, M3G 1.42 mg/kg and M6G 1.24 mg/kg 54 .
As discussed above vitreous is commonly used to confirm the use of heroin, via the detection showing that quantitation of morphine and its metabolites can be achieved.
Relationships between and femoral blood and the other various matrices
With the various states that bodies can be found in due to the manner of death or subsequent decomposition femoral blood may not be available. In the past it has been suggested that other biological samples may be used to predict the femoral blood sample for subsequent analysis 60 .
For this reason we investigated the correlation of femoral blood with the various matrices. For free morphine cardiac blood (R 2 = 0.79), bone marrow (R 2 = 0.70), muscle (R 2 = 0.69) and brain (R 2 = 0.73) significant correlations were observed, which were not seen with liver (R 2 = 0.49) and vitreous (R 2 = 0.44). These results in vitreous when compared to femoral blood are in agreement with a previous study (R 2 = 0.26; n=40 61 , as are the results of femoral blood to cardiac blood (R 2 = 0.76) and psoas muscle (R 2 = 0.75) 16 but don't agree with the results of two other studies that showed significant correlations between femoral blood and vitreous concentrations (R 2 = 0.87; p<0.01, n=69 62 ), (R 2 = 0.72; p<0.001, n=52 60 All matrices from different sites form three groups or classes in the plot: blood, bone marrow and brain at the bottom; muscle and liver at the top, vitreous by itself at the centre. The plot
shows that most biological samples are visually separable when the first three PCs are utilised,
with cardiac blood and brain showing highest correlation. However, a prediction of result could not be extrapolated since the r square of all possible combination was not higher than 0.87
(cardiac blood and brain) ( Table 6 ).
Results above 0.3mg/L for cardiac blood
In order to investigate whether our data corresponded to Logan's work 65 we also analysed data for morphine concentration in cardiac blood above and below 0.3mg/L.
In the PCA plot below (Fig. 2 ) PC1 contains 73.7 % while PC2 contains 10.6% and PC3 contains 6.7 % of the total variance. The situation represented in the plot was completely different from the previous ones, showing all matrices but vitreous grouped at the bottom of the plot, with bone marrow and brain overlaid, all the bloods close to each other, liver and muscle beside each other.
From the Pearson correlation table below brain and cardiac blood showed again to be the two matrices with the highest correlation. Cardiac blood and femoral blood r square was 0.7, cardiac blood and preserved femoral blood was 0.8 (Table 7) .
Results below 0.3mg/L for cardiac blood
For cardiac blood results below 0.3 mg/L the PCA plot and the Pearson table ( Fig. 3 and Table   7 ) showed a complete opposite situation compare to the one described by Logan. There was not significant correlation between cardiac and femoral blood with r square below 0.57. M6G may all undergo postmortem redistribution however this ratio may also however just represent anatomical site-to-site differences in drug concentration due to incomplete distribution before death 69 and more studies may be needed to confirm this.
Postmortem redistribution of morphine, morphine
Conclusions
The results of this study give 44 complete cases with morphine, M3G & M6G concentrations to help with the interpretation of heroin and morphine related cases. It is important to note this case series shows that when limited samples are available, such as in decomposition, it may not be possible to confirm the use of morphine/heroin with toxicological analysis and that M, M3G and M6G may undergo postmortem redistribution, complicating any interpretation. As with all toxicological interpretation should be carried out with as much information as possible. 
